TLDR:
- BrainCheck raised $15 million in a new financing round led by Next Coast Ventures, S3 Ventures, and UPMC Enterprises.
- The funding will accelerate BrainCheck’s commercial traction, expand innovation within its product portfolio, build upon existing clinical evidence, and extend its impact throughout the healthcare landscape.
BrainCheck, a digital health innovator in the digital cognitive assessment market, announced a $15 million new financing round led by Next Coast Ventures, S3 Ventures, and UPMC Enterprises. Nicholas Shapiro, Vice President of UPMC Enterprises, was appointed as a new board member to drive strategic leadership. The funding will accelerate the company’s commercial traction, expand innovation within its product portfolio, build upon existing clinical evidence, and extend its impact throughout the healthcare landscape, including integrations with major healthcare systems.
The announcement follows the recent launch of BrainCheck’s next-generation platform and 3-minute screening solution, allowing clinicians to screen and monitor patients’ cognitive function anytime, anywhere. BrainCheck’s platform is used by prominent providers and specialists in the country, offering a comprehensive solution across the cognitive care continuum, streamlining screening, assessment, care planning, and monitoring.
Key Quotes:
- “We are laser focused on commercializing and scaling a digital cognitive assessment platform that is clinically robust, easy for patients and their caregivers to use, enables a simplified provider experience and improves access to the actionable information needed to intervene sooner and potentially combat cognitive decline.” – Kim Rodriguez, CEO of BrainCheck
- “We believe in BrainCheck’s vision to pioneer a fundamental shift in how cognitive care is delivered. Dementia is projected to impact 14 million people in the United States and 152 million globally in the coming decades, underscoring the importance of proactive measures to address prevention, early detection, and effective management strategies.” – Michael Smerklo, Co-Founder and Managing Partner of Next Coast Ventures
- “Our decision to invest in BrainCheck is fueled by a deep understanding of the pressing burden of cognitive impairment on health care and the exciting solutions on the horizon to advance the industry.” – Nicholas Shapiro, Vice President, UPMC Enterprises
Source: Pulse 2.0
